On The Spot e-News
Volume 3, Issue 2 | February 2008
In this issue:
- Signature Profiled on "Washington Business in Focus"
- Signature at February Conferences
- 2008 Client Conference
Signature Profiled on "Washington Business in Focus"
Signature Genomic Laboratories was recently profiled on an episode of the television program "Washington Business in Focus".
Citing Signature as a "leader in using the human genome to diagnose mental retardation", the episode, titled "Life Sciences", focused on the company as an exemplar of the growth of life-sciences businesses in the state of Washington and their impact on the economy.
"Washington Business in Focus" is produced by the Washington State Public Affairs Network, a non-profit network devoted to coverage of Washington state government proceedings and public policy of statewide significance.
Visit Signature Genomic Laboratories at an event in February
Researchers from Signature Genomic Laboratories will be speaking at several events in February. Attend a platform presentation to meet members of the Signature team and learn more about the power of Signature microarrays.
Society for Maternal-Fetal Medicine Annual Meeting, Dallas, TX Jan. 28 - Feb. 2
- Scientific Forum on Genetics: Current Application of Microarray Testing in Prenatal Diagnosis. Presented by Dr. Lisa G. Shaffer, Ph.D., President and CEO of Signature. Thurs. Jan. 30, 5:00pm.
Montreal Children's Hospital Pediatric Grand Rounds, Montreal, Quebec, Feb. 27.
- Presentation: Medical Applications of Array CGH and the Transformation of Clinical Cytogenetics. Presented by Dr. Bassem A. Bejjani, M.D., Chief Medical Officer of Signature. Weds. Feb. 27, 8:00am.
- Wine and Cheese Reception with Presentation: Medical Applications of Array CGH and the Transformation of Clinical Cytogenetics. Presented by Dr. Bassem A. Bejjani. Weds. Feb. 27, 5:30pm.
2008 Client Conference
Signature Genomic Laboratories announces the first Signature Scientific Microarray Conference, on June 20-21, 2008 at the Doubletree Hotel Spokane City Center. Open to all Signature clients, the conference will focus on array CGH in the laboratory and the diagnostic clinic, present and future. The conference will include sessions that discuss technical aspects of the technology, discoveries of previously unrecognized syndromes, and newly recognized genomic variations (CNVs). Signature has carefully structured the conference and limited attendance to allow rapid dissemination of information that will assist in driving this emerging field forward for the benefit of your patients. With an intimate atmosphere, the Signature Scientific Microarray Conference will encourage sharing of information and lively discussions to benefit all medical providers of array CGH.
Signature encourages the submission of abstracts focusing on clinical aspects and technical methodologies of array CGH by April 11, 2008. Please note that most submitted abstracts will be selected for platform presentations.